Tretinoin [clinicaltrials_resource:6b35594592f1bd6c45d68a7b48b7e7ba]
Feasibility of Retinoic Acid Treatment in Emphysema (FORTE) [clinicaltrials:NCT00000621]A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes [clinicaltrials:NCT00001438]A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients [clinicaltrials:NCT00001504]A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor [clinicaltrials:NCT00001509]Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome [clinicaltrials:NCT00002479]clinicaltrials:NCT00002586Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas [clinicaltrials:NCT00003564]UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia [clinicaltrials:NCT00003598]Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer [clinicaltrials:NCT00003599]Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome [clinicaltrials:NCT00003601]Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer [clinicaltrials:NCT00003656]Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia [clinicaltrials:NCT00003934]Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00005863]Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease [clinicaltrials:NCT00005969]clinicaltrials:NCT00006220Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006239]Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer [clinicaltrials:NCT00007631]Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma [clinicaltrials:NCT00026312]clinicaltrials:NCT00062010clinicaltrials:NCT00100906A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [clinicaltrials:NCT00136461]clinicaltrials:NCT00138151Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT00151242]All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT00151255]Differentiation Induction in Acute Myelogenous Leukemia [clinicaltrials:NCT00175812]clinicaltrials:NCT00200161clinicaltrials:NCT00240513clinicaltrials:NCT00326170Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery [clinicaltrials:NCT00334789]5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS [clinicaltrials:NCT00339196]clinicaltrials:NCT00382200All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab [clinicaltrials:NCT00413166]Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid [clinicaltrials:NCT00437450]Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma [clinicaltrials:NCT00472966]clinicaltrials:NCT00482833clinicaltrials:NCT00492856Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00514293]clinicaltrials:NCT00528437clinicaltrials:NCT00528450clinicaltrials:NCT00533169
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Tretinoin [clinicaltrials_resource:6b35594592f1bd6c45d68a7b48b7e7ba]
Bio2RDF identifier
6b35594592f1bd6c45d68a7b48b7e7ba
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6b35594592f1bd6c45d68a7b48b7e7ba
identifier
clinicaltrials_resource:6b35594592f1bd6c45d68a7b48b7e7ba
title
Tretinoin
@en
type
label
Tretinoin [clinicaltrials_resource:6b35594592f1bd6c45d68a7b48b7e7ba]
@en